Rongchang Bio is a developer of treatments for cancer and autoimmune diseases. It is committed to developing innovative treatment methods for patients with cancer, ophthalmic diseases and autoimmune diseases, and has independently developed Tatasip, a drug for treating systemic lupus erythematosus, rheumatoid arthritis and other autoimmune diseases.

More peer analysis, the company knows and understands.